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Photodynamic therapy works with a photosensitizer that is stimulated when exposed to a light source of a specific 
wavelength and produces a form of oxygen that can be used in cancer treatments. In this study, we investigated the effect of 
laser on apoptosis on breast cancer cell lines (MDA-MB-231) treated with verteporfin in cell culture media. Verteporfin 
added MDA-MB-231 cells were incubated without light for 24 hours after applying laser light at a wavelength of 695 nm at 
an intensity of 50 J/cm2 at various times. Anti-proliferative effects were evaluated by immunoreactivity of anti-Bcl-2 and 
anti-Bax antibodies by immunocytochemical staining. When anti-Bax/Anti-Bcl-2 ratio are compared, the ratio of 1.5 in the 
control group cells decreases in short-term laser applications, while it approaches normal values in the 7th min after long-
term laser application and reaches a very high value in the 9th min. Therefore, our results suggest that verteporfin-mediated 
PDT may be a potential combined therapy strategy against breast carcinoma by increasing apoptosis. 
Keywords: Bax, Bcl-2, Laser, MDA-MB-231, Photosensitizer 
Breast cancer is the leading cause of cancer-related 
deaths worldwide and is the most common type of 
cancer among women. Despite advances in molecular 
classification and treatment, breast cancer incidence 
and mortality remain high
1
. New therapeutic strategies 
are needed because of the resistance to the current 
treatment modalities of metastatic, triple- negative 
breast cancer cases that lack estrogen receptor, 
progesterone receptor, and human epidermal growth 
factor receptor. Nowadays, it is seen that photodynamic 
therapy (PDT), which is one of the alternative 
treatments, has become widespread in the treatment of 
cancer without damaging healthy tissues. The method 
of PDT is based on the application of a substance that 
sensitizes the tissue called photosensitizer (PS), which 
is treated with the light of a specific wavelength that 
accumulates to some extent in the pathological tissue. 
PDT is based on the principle of the effect of 
photochemical reaction on the cells resulting from the 
interaction of the photosensitive molecules with light. 
The reactive oxygen products produced by PDT can 
have a direct harmful effect on the cells or they may 
cause damage to the cells due to organelle damage or 
cell membrane damage
2
. The response to PDT at the 
cellular level depends on the localization of the 
photosensitizing agent. The localization of the 




Depending on their characteristics, a photosensitizing 
agent is generally localized to organelles such as the 
plasma membrane, lysosomes, mitochondria, Golgi 
apparatus, or endoplasmic reticulum (ER)
4
. PDT is 
thought to be the three main tumor destruction 
mechanisms. Due to the localization and activation of 
photosensitivity agents in the tumor tissue, reactive 
oxygen species (ROS) can directly kill malignant tumor 
cells. Oxidative stress caused by increased intracellular 
ROS concentration usually progresses through 
dangerous processes such as lipid peroxidation, 
oxidative modification of nucleic acids and proteins, 
however, it plays a signal and regulatory role in the 
organism
5
. The direct cell killing effect of PDT on both 
the tumor parenchyma and stroma occurs due to the 
formation of ROS on the presence of oxygen
6
. On the 
other hand, PDT may target the tumor vessel structures 
and prevent the supply of oxygen and essential nutrients. 
Damaging existing vessel formation or inhibiting new 
vessel formation has detrimental consequences for 
tumor proliferation, and based on this, anti-angiogenic 
therapeutics are clinically applied for the treatment of 
cancers
7
. The third mechanism of PDT-induced tumor 
destruction is the initiation of an inflammatory response 








oxidative stress can upregulate the expression of heat 
shock proteins (HSP), transcription factors associated 
with inflammation and release of inflammatory 
cytokines
8
. After PDT, HSPs such as HSP70 have been 
shown to be upregulated or expressed on the cell 
surface
9
. HSP may bind to tumor antigens and interact 
with Toll-like receptors (TLRs), which are the main 
means of activating antigen- presenting cells (APC). In 
addition, these interactions regulate the expression of the 
inflammatory and immune response genes. Other 
damage- associated molecular patterns (DAMPs) 
observed after PDT are lipid fragments and arachidonic 
acid metabolites, membrane degradation products such 
as adenosine triphosphate (ATP), or ER protein 
calreticulin
10
. Increased expression and activation of 
transcription factors such as nuclear factor κB (NF-κB) 
and activator protein 1 (AP1) are also an important 
mechanism in inducing an inflammatory response 
following PDT-induced oxidative stress. Numerous 
studies with different PSs have increased NF-κB and 
AP1 transcription factors after PDT
11
. 
Verteporfin (VP), a third- generation PS, has been 
widely used to treat macular degeneration and has 
been proposed to be used for cancer treatment  
in recent years. The mouse liver cancer model and  
in vitro colon cancer research has demonstrated that 
VP is effective in cancer treatment. However, the 
mechanisms by which VP inhibits cancer growth are 
not yet well known
12
. The therapeutic efficacy of PDT 
depends on the properties of light used to activate PS. 
The light has to penetrate the skin and the tissue to 
reach the target area
13
. Lasers are widely used in PDT 
because of their potency and can be interstitially 
distributed to deep-seated tumors and attached to 
optical fibers that can be used with the application of 
diffusion tips. Verteporfin is characterized by an 
intense absorption band in the red region of the visible 
spectrum which is capable of penetrating the tissue 
deeper than other visible wavelengths
14
. 
PDT has been suggested to induce -cell Lymphoma 
2 (Bcl-2) and activate proapoptotic mechanisms
15
. 
Changes in the Bcl-2 family after PDT have been 
demonstrated in cell lines and cancer cells. In a study to 
investigate the effects of verteporfin on apoptosis  
in NB4 human leukemia cell line, expression levels of 
Bcl-2, and Bcl-2 associated X (Bax) proteins showed 
significant changes after verteporfin administration. 
Consistently, increased Bax and decreased Bcl-2 
expression were observed in VP treatment groups 
compared to the control group
16
.  
PDT has been proposed to be used in cancer 
treatments and breast cancer cases. Although the 
clinical success of promising stage III trials of PDT 
has been approved for cancer treatment, it is still not 
widely used in clinical practice. However, the dose of 
verteporfin to be used and the mechanism of laser 
energy are not fully known. The aim of this study was 
to investigate the effect of laser on apoptosis on breast 
cancer cells treated with verteporfin in cell culture 
media. 
 
Materials and Methods 
The study was carried out in Manisa Celal Bayar 
University Faculty of Medicine, Department of 
Histology and Embryology. 
 
Cell culture 
MDA-MB-231 breast cancer cells were maintained 
in Roswell Park Memorial Institute (RPMI) 1640 
supplemented containing 10% fetal bovine serum, 1% 
penicillin-streptomycin, 1% L-Gluthamine in an 
environment with 5% CO2 at 37°C. 
 
Determination of IC50 of verteporfin by MTT 
(Methylthiazolyldiphenyl-tetrazolium bromide) Assay 
MDA-MB-231 cells were seeded at 5000 cells per 
well of a 96-well culture plate. Cells were incubated 
at 37C and 5% CO2
 
for 24 h and then exposed to 
increasing doses of verteporfin for 72 h. Then 10 μL 
of MTT was added to each well and incubated for 4 h. 
Drug concentration (IC50 -The half maximal 
inhibitory concentration) resulting in 50% inhibition 
of cell proliferation was calculated after measurement 
at a wavelength of absorbance density 490 nm. 
 
Verteporfin and laser application to cells 
After MDA-MB-231 breast cancer cells were 
seeded on 8-well cell culture slides, the verteporfin 
dose with the determined IC50 value was added to 
each well. Verteporfin was activated by stimulating 
the cells with a laser beam at a wavelength of 695 nm 
at an intensity of 50 J/cm
2
. Diode laser was applied to 
each group for 3, 5, 7, and 9 min. The laser beam 
diameter was determined according to the eye 
diameter of the 8-well cell culture slides on which cell 
transplantation was performed. 
 
Indirect immunohistochemical staining of cells 
After 24 h of incubation, the cells were fixed with 
10% paraformaldehyde. The cells were washed 3 times 
with phosphate- buffered saline (PBS) for 5 min, then 
kept on ice for 15 min in triton-X solution to increase 




membrane permeability. Subsequently, 3% H2O2 was 
applied for 5 min to inhibit endogenous peroxidase 
activity of the cells. The cells were washed 3 times with 
PBS solution for 5 min and treated with 1 h blocking 
solution. After the blocking solution was removed from 
the cells, the primary antibodies were incubated with 
Bcl-2 and Bax overnight at +4C. The next day, cells 
washed 3 times with PBS solution were stained with 
anti-mouse biotin-streptavidin secondary antibody for  
30 min. Cells were stained with 3, 3-diaminobenzidine 
tetrahydrochloride hydrate (DAB) for 5 min to 
determine the visibility of the immunohistochemical 
reaction. After Mayer’s hematoxylin background 
staining, cells washed with distilled water were covered 
with mounting medium.  
 
Statistical analysis 
The immunohistochemical staining results were 
evaluated by H-score. After the staining rate was 
graded semiquantitatively (Staining rate, 0 = staining in 
less than 1% of cells; 1+ = staining in 1-10% of cells; 
2+ = staining in 11-50% of cells; 3+ = staining in  
51-80% of cells; 4+ = by staining in more than 80% of 
cells; staining intensity 0 = no staining; 1 = pale;  
2 = intermediate; 3 = intensive ), the total score was 
calculated with the formula ―(1 + staining intensity/3)  
staining rate‖. The differences between the groups and 
the findings were determined by one-way ANOVA test 
and P <0.05 was considered statistically significant. 
 
Results and Discussion 
The safe and effective dose of verteporfin 
administered to breast cancer cells was calculated to be 
0.5 mg/kg using the therapeutic window and was 
administered with 490 J laser with light energy. In a 
study by Jiang Y et al. verteporfin was administered to 
MDA-MB-231 cells at doses of 0, 4, 8, 12 and  




VP has been suggested to reduce cancer cell 
proliferation
18
. However, the mechanism of action of VP 
on the proliferation of cancer cells is not fully known, it 
is known that verteporfin down regulates Yes- 
associated protien 1 - Transcriptional enhanced associate 
domain (YAP-TEAD) complex in epithelial carcinomas 
and prevents uncontrolled proliferation. This mechanism 
facilitates cancer treatment by specifically affecting 
cancer cells without damaging healthy cells
19,20
.  
A study by Liang Dong et al. they showed that 
verteporfin applied in bladder cancer stopped the 
growth and invasion of cancer cells by suppressing the 
Hippo signaling pathway
21
. In addition, treatment with 
VP has been shown to cause downregulation of cyclin 
D1 and cyclin E1, modulation of Bcl-2 family proteins, 
and Poly ADP ribose polymerase (PARP) activation. It 
has been reported that VP has an inhibitory effect on 
angiogenesis and vasculogenesis by suppressing 
angiogenin ribonuclease A family member 2 (Ang2), 
matrix metalloproteinase-2 (MMP2), and cadherin, and 
alpha smooth muscle actin (α-SMA) expression  
in vitro and in vivo
22
.  
Bcl-2, a regulator classified as an oncogen 
mediating cell death, acts as an anti-apoptotic protein. 
Decreased anti-apoptotic Bcl-2 protein in pathogenetic 
processes contributes to cancer treatment by increasing 
apotosis, while overproduction is known to accelerate 
cancer development.  
Bcl-2 can form heterodimers and can be used as an 
anti-apoptotic regulator. In contrast, Bax, another 
regulator of apoptosis, binds Bcl-2 protein and 
suppresses it. This, in turn, triggers cell death. In this 
study, it was seen that there was a decrease in Bcl-2 
activity compared to the control group in MDA-MB-231 
cells treated with Verteporfin and laser in the 3
rd
 min. 
Bcl-2 levels returned to normal at the 5
th
 min and 




 min. It was 
thought that the effect of photodynamic therapy on Bcl-2 
started to show from the 3
rd
 min but this effect was not 
applied in the 5
th
 min. The Bcl-2 family of proteins is 
known to be a key regulator of apoptosis and an 
important determinant of cell fate. Bcl-2 exhibits 
antiapoptotic function and is known to exert its effect by 
disrupting the integrity of the outer mitochondrial 
membrane. In vertebrates, they release intermembrane 
space proteins such as cytochrome c to promote caspase 
activation in cytochrome. It has been reported that 
Verteporfin significantly inhibits expression of c-MYC, 
cyclin D1, YAP, Cysteine-rich angiogenic inducer 61 
(CYR61) and Connective tissue growth factor (CTGF), 
as well as significantly inhibiting cell proliferation, 
invasion and migration by downregulating the 
expression of their target genes CYR61 and CTGF
23
. 
Verteporfin is known to have a reducing effect on Bcl-2. 
In a study of CAL27 cells treated with Verteporfin, it 




In this study, it was observed that Bcl-2 activity of 
verteporfin and laser-treated MDA-MB-231 cells 










 min (Figs. 1 & 2). 




It is known that Bax undergoes structural changes in 
order to trigger apoptosis in cancer tissue, and it acts by 
interacting with the organelle membrane, especially the  
mitochondrial membrane. As a result of inhibition of  
bax expression by gene silencing, it has been shown  
that Bax has no effect on mitochondrial depolarization 
and cytochrome c release and does not contribute  
to mitochondrial outer membrane permeabilization 
(MOMP) after PDT. It has been reported that Bax 
activation is not necessary for mitochondrial outer 
membrane permeabilization but is required for dynamin  
 
 
Fig. 1 — The immunoreactivity of Bcl-2 on MDA-MB-231 cells 
untreated (a, b, c) and treated for 3 min. (d, e, f), 5 min. (g, h, i),  
7 min. (j, k, l) and 9 min. (m, n, o) laser with verteporfin. Arrows 
indicate Bcl-2 positive cells with brown cytoplasmic staining 
(hematoxylene, Scale bar of a, d, g, j, m: 50 μM; b, e, h, k, n:  




Fig. 2 — Distribution of anti-Bcl-2 immunoreactivity according to 
laser dose applied to MDA-MB-231 cells. Experiments were 
performed in triplicate and repeated three times with similar 
results. Bars display mean ± SD. One-way ANOVA (P <0.05) 
was performed using GraphPad Prism 7® to test the differences of 
anti-Bcl-2 immunoreactivity between control and 3, 5, 7, 9 min 
laser treated clams 
 
 
Fig. 3 — The immunoreactivity of Bax on MDA-MB-231 cells 
untreated (a, b, c) and treated for 3 min. (d, e, f), 5 min. (g, h, i),  
7 min. (j, k, l) and 9 min. (m, n, o) laser with verteporfin. Arrows 
indicate Bax positive cells with brown cytoplasmic staining 
(hematoxylene, Scale bar of a, d, g, j, m: 50 μM; b, e, h, k, n:  




Fig. 4 — Distribution of anti-Bax-2 immunoreactivity according 
to laser dose applied to MDA-MB-231 cells. Experiments were 
performed in triplicate and repeated three times with similar 
results. Bars display mean ± SD. One-way ANOVA (P <0.05) 
was performed using GraphPad Prism 7® to test the differences of 
anti-Bax-2 immunoreactivity between control and 3, 5, 7, 9 min 
laser treated clams 




related protein 1 (Drp1) mediated mitochondrial fission 
during apoptosis caused by Photofrin – PDT
24
.  
The correlations between Bax protein, p53, and 
caspase-3 expression are probably known to be 
associated with an active apoptotic mechanism in breast 
cancer cells expressing Bax protein. The ratio of anti-
pro-apoptotic molecules constitutes a mechanism for 
accelerating pore formation in the mitochondrial outer 
membrane, determining the susceptibility threshold to 
apoptosis for the intrinsic apoptotic pathway, which 
leads to loss of mitochondrial integrity and release of 
cytochrome.  
In the immunohistochemical examination of the 
breast cancer cell line treated with verteporfin and PDT, 
it was found that Bax expression of the cells was higher 
in the control group, whereas the immunoreactivity was 
low in the 3 and 5 min laser treated cells, whereas it 
increased gradually in the 7 and 9 min laser- treated cells 
(Figs. 3 & 4). 
It has been reported that Bcl-2 is upregulated and  
Bax is down-regulated in the HT29 human colon  
cancer adenocarcinoma cell line that is resistant  
to photodynamic therapy
25
. 5-Aminolevulinic Acid  
(5-ALA), another photosensitive agent whose PDT 
effects were investigated, was shown to suppress the 
level of Bcl-2 mRNA and increase the level of Bax 
mRNA in cervical and esophageal cancer cells
26
. On the 
other hand, in phototherapy applications using aluminum 
phthalocyanine, MCF10A human breast cancer cells has 
been shown to respond very well to treatment even 
though Bcl-2 overexpression is observed in it
27
. 
According to this opposite view, Bcl-2 transfection 
results in both Bcl-2 and Bax overexpression, and 
mitochondrial photo-damage selectively causes Bcl-2 
reduction but not Bax. Thus, this situation is interpreted 
as increasing Bcl-2/Bax ratio
28
. Similar results have been 
published by Srivastava et al. Apoptosis was induced by 
Pc4-PDT in RIF1 and A431 cell lines and increased 
apoptosis was observed with increasing bax protein in 
A431 cell line. In this study, Bcl-2/Bax ratio was also 
increased. The antisense Bcl-2 oligonucleotide in the 
RIF1 cell line significantly reduced apoptosis after 6 h
29
. 
In a recent study, it was suggested that the Bcl-2/Bax 
ratio in breast cancer cells had the ability to reduce 
apoptosis physiologically by numerical regulation
30
. In 
this study, when the Bax/Bcl-2 ratios were compared, 
the ratio of the cells in the control group was 1.5 while it 
decreased in the short-term applications, but after the 
long-term application, it approached normal in the  
7
th
 min and reached a very high value in the 9
th
 min. In a 
study by Qiao Z et al. when they applied laser (670 nm, 
10 J/cm
2
) to CPF4 photosensitizer chrolophyll derivative 
treated MCF-7 breast cancer cells, they found that Bcl-2 
protein was downregulated, whereas Bax protein was 
overexpressed and therefore Bcl-2/Bax ratio decreased. 
Researchers have reported that the application of 
photosensitizer 2-devinyl-2-[1-methoxylethyl] chlorin f 
(CPD4) or PDT alone does not cause apoptosis in cells, 




The Bcl-2 family is known to be a mitochondrial 
permeability transition pore regulator, inhibiting 
transitions, and playing an important role in providing 
membrane potential. Bax is located in the cytoplasm and 
acts in the opposite direction of Bcl-2 in mitochondrial 
permeability transition pore regulation. Therefore, it is 




In our study, when the Bax/Bcl-2 ratios were 
compared, the ratio was 1.5 in the cells of the control 
group while the rate decreased in the short-term 
applications, but after the long-term application, it 
approached normal in the 7
th
 min and reached the very 
high value in the 9
th
 min (Table 1). 
 
Conclusion 
PDT is a treatment performed by applying a 
photosensitive agent deposited in tumor tissue. After an 
incubation time that sensitizes the target tissue to light, 
visible light at a wavelength that matches the absorption 
of a photosensitive agent is applied to the target tissue. 
In PDT applications, in the presence of oxygen, light 
activation of photosensitive agents results in reactive 
oxygen products and causes photochemical reactions. It 
Table 1 — Quantitative regulation of Bcl-2/Bax ratio in MDA-MB-231 breast cancer cells in all groups 
 Control Laser 
Time/Min -- 3 Min 5 Min 7 Min 9 Min 
Energy -- 108 j/s2 180 j/s2 252j/s2 324j/s2 
Bax 135, 76, 49 8910, 49 103, 511, 81 145, 26, 23 187, 613, 17 
Bcl-2 86, 15, 66 824, 07 88, 15, 06 96, 45, 25 107, 34, 81 
Bax/Bcl-2 1.570, 08 1.080, 12 1.170, 16 1.510, 09 1.740, 05 




is claimed that the resulting oxygen has a cytotoxic 
effect and thus causes the destruction of tumor cells.  
In this study, we tried to observe the anti-proliferative 
and apoptotic effects of phototherapy on MDA-MB-231 
cells in cell culture medium. For this, after adding 
verteporfin to the medium of MDA-MB-231 cells, we 
applied laser light of 695 nm wavelength at 50 J/cm2 
intensity at various times. Next, we evaluated the 
immunoreactivities of Anti-Bax and Anti-Bcl-2 
antibodies. In our results, Bax/Bcl-2 ratio increased from 
the 7
th
 min, and it was observed more clearly after 9 min 
of laser applications. These results showed us that the 
enhanced in vitro antitumor effect of PDT combined 
with verteporfin through Bax/Bcl-2 molecules can 
regulate intrinsic apoptotic pathways that lead to tumor 
apoptosis. 
Taken together, PDT combined with verteporfin 
resulted in inhibition of cell proliferation and 
increased apoptosis in vitro. Cancer treatments to be 
performed with such applications may be an important 
treatment regimen for the prevention of cancers with 
local effects while protecting from the systemic effects 
of general chemotherapeutic agents. Therefore, our 
results show that verteporfin-mediated PDT is a 
potential combined treatment strategy against breast 
carcinoma. However, further studies are needed to 
develop this finding. 
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